Bogavac Mirjana, Lakic Neda, Simin Natasa, Nikolic Aleksandra, Sudji Jan, Bozin Biljana
Department of Obstetrics and Gynecology, Vojvodina Clinical Centre, Novi Sad, Serbia.
J Matern Fetal Neonatal Med. 2012 Jan;25(1):104-8. doi: 10.3109/14767058.2011.560625. Epub 2011 Mar 10.
In this study, we tried to determine whether the activities of the primary antioxidant enzymes are detectable in amniotic fluid and whether they can be used as early biomarkers of complications in pregnancy such as pregnancy-induced hypertension (PIH), gestational diabetes mellitus (GDM), and bacterial vaginosis.
This was a prospective study in which amniotic fluid was taken between 16 and 19 week of gestation. In all, 161 pregnant women were divided into two groups: study group - patients with the treated local infection, PIH, and GDM, and control group - healthy pregnant women. Levels of reduced glutathione (GSH) and activities of supeoxide dismutase (SOD), glutathione peroxidase (GSH-Px), glutathione reductase (GSHR), glutathione S-transpherase (GST), xanthine oxidase (XOD) and lipid peroxidation (LP) were determined spectrophotometrically in amniotic fluid samples.
Concentration of malondialdehyde varied greatly between investigated groups. XOD and SOD activities, though very low, were present in amniotic fluid samples. Also, enzymes of glutathione cycle and GSH concentrations were detectable and showed certain variations.
Parameters of oxidative stress in amniotic fluid could be altered in certain pathological conditions. Their use as clinical biomarkers is limited due to great variations of amniotic fluid volume between patients which gives favor to hemolysate or serum of pregnant women.
在本研究中,我们试图确定羊水内是否可检测到主要抗氧化酶的活性,以及它们是否可作为妊娠并发症如妊娠高血压(PIH)、妊娠期糖尿病(GDM)和细菌性阴道病的早期生物标志物。
这是一项前瞻性研究,在妊娠16至19周期间采集羊水。总共161名孕妇被分为两组:研究组——患有局部感染、PIH和GDM的患者,以及对照组——健康孕妇。采用分光光度法测定羊水样本中还原型谷胱甘肽(GSH)的水平、超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)、谷胱甘肽还原酶(GSHR)、谷胱甘肽S-转移酶(GST)、黄嘌呤氧化酶(XOD)的活性以及脂质过氧化(LP)情况。
丙二醛浓度在各研究组之间差异很大。羊水样本中存在XOD和SOD活性,尽管其活性非常低。此外,谷胱甘肽循环的酶和GSH浓度是可检测到的,并且呈现出一定的变化。
在某些病理状况下,羊水内氧化应激参数可能会发生改变。由于患者之间羊水量差异很大,这有利于孕妇的溶血产物或血清,因此将其用作临床生物标志物受到限制。